From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed...
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed...
The cochairs of the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers—Andrew Futreal, PhD, FAACR,...
What are fusion proteins? Learn more about how improperly combined genes and their protein products can lead to cancer.
At an AACR special conference on early-onset cancers, researchers discussed microplastics, the global rise of these cancers, and more.
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.
New insights into the neurologic and physiologic impact of chronic stress on ovarian cancer were presented at two recent...
Shawn Lee, MD, PhD, an AACR-St. Baldrick’s Foundation Grantee, is working to personalize therapies for children with acute lymphoblastic...
Laura M. Heiser, PhD, and Mara H. Sherman, PhD share insights on cancer evolution as they preview an upcoming...
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.